| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent activity | NSF DHX40 CECR2 NTPCR COQ8B ABCC5 CHD9 ZNFX1 ACSF2 DNAH7 RAD50 ABCC2 MTREX DDX24 SNRNP200 HSPA14 ATP4A DDX11L8 | 7.07e-07 | 614 | 148 | 18 | GO:0140657 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | NSF DHX40 NTPCR COQ8B ABCC5 CHD9 DNAH7 RAD50 ABCC2 MTREX DDX24 SNRNP200 HSPA14 ATP4A DDX11L8 | 1.03e-06 | 441 | 148 | 15 | GO:0016887 |
| GeneOntologyMolecularFunction | benzodiazepine receptor binding | 3.95e-06 | 5 | 148 | 3 | GO:0030156 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | PLPP5 NSF DHX40 NTPCR COQ8B ABCC5 CHD9 GTPBP1 DNAH7 RAD50 GNAI1 GNAI3 ABCC2 MTREX DDX24 RAB3B SNRNP200 HSPA14 ATP4A DDX11L8 | 3.98e-06 | 839 | 148 | 20 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | PLPP5 NSF DHX40 NTPCR COQ8B ABCC5 CHD9 GTPBP1 DNAH7 RAD50 GNAI1 GNAI3 ABCC2 MTREX DDX24 RAB3B SNRNP200 HSPA14 ATP4A DDX11L8 | 4.06e-06 | 840 | 148 | 20 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | PLPP5 NSF DHX40 NTPCR COQ8B ABCC5 CHD9 GTPBP1 DNAH7 RAD50 GNAI1 GNAI3 ABCC2 MTREX DDX24 RAB3B SNRNP200 HSPA14 ATP4A DDX11L8 | 4.06e-06 | 840 | 148 | 20 | GO:0016818 |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | NSF DHX40 NTPCR COQ8B ABCC5 CHD9 GTPBP1 DNAH7 RAD50 GNAI1 GNAI3 ABCC2 MTREX DDX24 RAB3B SNRNP200 HSPA14 ATP4A DDX11L8 | 4.76e-06 | 775 | 148 | 19 | GO:0017111 |
| GeneOntologyMolecularFunction | helicase activity | 2.38e-05 | 158 | 148 | 8 | GO:0004386 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor | 3.24e-05 | 9 | 148 | 3 | GO:0016624 | |
| GeneOntologyMolecularFunction | tRNA-4-demethylwyosine synthase activity | 5.46e-05 | 2 | 148 | 2 | GO:0102521 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | ERCC4 POLA1 DHX40 POLE CECR2 PIWIL4 CHD9 ZNFX1 RAD50 TYW1B TYW1 MTREX DDX24 SNRNP200 DDX11L8 | 9.19e-05 | 645 | 148 | 15 | GO:0140640 |
| GeneOntologyMolecularFunction | pyruvate dehydrogenase (acetyl-transferring) activity | 1.63e-04 | 3 | 148 | 2 | GO:0004739 | |
| GeneOntologyMolecularFunction | iron-sulfur cluster binding | 2.86e-04 | 78 | 148 | 5 | GO:0051536 | |
| GeneOntologyMolecularFunction | RNA helicase activity | 2.86e-04 | 78 | 148 | 5 | GO:0003724 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on RNA | 3.21e-04 | 80 | 148 | 5 | GO:0008186 | |
| GeneOntologyMolecularFunction | metal cluster binding | 3.81e-04 | 83 | 148 | 5 | GO:0051540 | |
| GeneOntologyMolecularFunction | 4 iron, 4 sulfur cluster binding | 4.03e-04 | 47 | 148 | 4 | GO:0051539 | |
| GeneOntologyMolecularFunction | G protein-coupled serotonin receptor binding | 5.38e-04 | 5 | 148 | 2 | GO:0031821 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase binding | 7.20e-04 | 24 | 148 | 3 | GO:0120283 | |
| GeneOntologyMolecularFunction | all-trans-retinol dehydrogenase (NAD+) activity | 7.20e-04 | 24 | 148 | 3 | GO:0004745 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the aldehyde or oxo group of donors | 7.89e-04 | 56 | 148 | 4 | GO:0016903 | |
| GeneOntologyMolecularFunction | carbon-carbon lyase activity | 7.89e-04 | 56 | 148 | 4 | GO:0016830 | |
| GeneOntologyMolecularFunction | ethanol binding | 8.03e-04 | 6 | 148 | 2 | GO:0035276 | |
| GeneOntologyMolecularFunction | telomerase inhibitor activity | 8.03e-04 | 6 | 148 | 2 | GO:0010521 | |
| GeneOntologyMolecularFunction | pyruvate dehydrogenase (NAD+) activity | 8.03e-04 | 6 | 148 | 2 | GO:0034604 | |
| GeneOntologyMolecularFunction | pyruvate dehydrogenase [NAD(P)+] activity | 8.03e-04 | 6 | 148 | 2 | GO:0034603 | |
| GeneOntologyMolecularFunction | pyruvate dehydrogenase activity | 8.03e-04 | 6 | 148 | 2 | GO:0004738 | |
| GeneOntologyMolecularFunction | G-protein beta/gamma-subunit complex binding | 8.14e-04 | 25 | 148 | 3 | GO:0031683 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase (NAD+) activity | 9.15e-04 | 26 | 148 | 3 | GO:0004022 | |
| GeneOntologyMolecularFunction | clathrin light chain binding | 1.12e-03 | 7 | 148 | 2 | GO:0032051 | |
| GeneOntologyMolecularFunction | oxo-acid-lyase activity | 1.12e-03 | 7 | 148 | 2 | GO:0016833 | |
| GeneOntologyMolecularFunction | clathrin binding | 1.23e-03 | 63 | 148 | 4 | GO:0030276 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase [NAD(P)+] activity | 1.40e-03 | 30 | 148 | 3 | GO:0018455 | |
| GeneOntologyMolecularFunction | ATPase-coupled inorganic anion transmembrane transporter activity | 2.36e-03 | 10 | 148 | 2 | GO:0043225 | |
| GeneOntologyBiologicalProcess | neuromuscular synaptic transmission | 4.73e-06 | 36 | 143 | 5 | GO:0007274 | |
| GeneOntologyCellularComponent | clathrin coat | 2.08e-06 | 56 | 141 | 6 | GO:0030118 | |
| GeneOntologyCellularComponent | clathrin vesicle coat | 5.46e-06 | 38 | 141 | 5 | GO:0030125 | |
| GeneOntologyCellularComponent | clathrin coat of trans-Golgi network vesicle | 5.64e-06 | 18 | 141 | 4 | GO:0030130 | |
| GeneOntologyCellularComponent | vesicle coat | 6.02e-06 | 67 | 141 | 6 | GO:0030120 | |
| GeneOntologyCellularComponent | coated membrane | 7.64e-06 | 106 | 141 | 7 | GO:0048475 | |
| GeneOntologyCellularComponent | membrane coat | 7.64e-06 | 106 | 141 | 7 | GO:0030117 | |
| GeneOntologyCellularComponent | trans-Golgi network transport vesicle membrane | 1.32e-05 | 22 | 141 | 4 | GO:0012510 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | HDAC9 ERCC4 IPO7 TENT4A POLA1 POLE CECR2 HNRNPM ZNFX1 BRCC3 RBM28 MED13L LSM5 CXXC1 RAD50 INTS14 ARID2 FRG1 CLTC MTREX TEN1 SNRNP200 DDX11L8 | 4.81e-05 | 1377 | 141 | 23 | GO:0140513 |
| GeneOntologyCellularComponent | clathrin adaptor complex | 5.42e-05 | 31 | 141 | 4 | GO:0030131 | |
| GeneOntologyCellularComponent | Golgi-associated vesicle membrane | 5.71e-05 | 61 | 141 | 5 | GO:0030660 | |
| GeneOntologyCellularComponent | trans-Golgi network transport vesicle | 1.50e-04 | 40 | 141 | 4 | GO:0030140 | |
| GeneOntologyCellularComponent | extrinsic component of membrane | 1.72e-04 | 230 | 141 | 8 | GO:0019898 | |
| GeneOntologyCellularComponent | transport vesicle membrane | 1.72e-04 | 293 | 141 | 9 | GO:0030658 | |
| GeneOntologyCellularComponent | presynaptic endocytic zone | 2.28e-04 | 18 | 141 | 3 | GO:0098833 | |
| GeneOntologyCellularComponent | alpha-ketoacid dehydrogenase complex | 2.28e-04 | 18 | 141 | 3 | GO:0045240 | |
| GeneOntologyCellularComponent | AP-type membrane coat adaptor complex | 3.07e-04 | 48 | 141 | 4 | GO:0030119 | |
| GeneOntologyCellularComponent | TRAMP complex | 4.46e-04 | 5 | 141 | 2 | GO:0031499 | |
| GeneOntologyCellularComponent | clathrin-coated vesicle membrane | 4.91e-04 | 147 | 141 | 6 | GO:0030665 | |
| GeneOntologyCellularComponent | coated vesicle membrane | 6.52e-04 | 215 | 141 | 7 | GO:0030662 | |
| GeneOntologyCellularComponent | striated muscle thin filament | 7.80e-04 | 27 | 141 | 3 | GO:0005865 | |
| GeneOntologyCellularComponent | Golgi apparatus subcompartment | 8.64e-04 | 443 | 141 | 10 | GO:0098791 | |
| GeneOntologyCellularComponent | manchette | 8.70e-04 | 28 | 141 | 3 | GO:0002177 | |
| GeneOntologyCellularComponent | presynapse | GAD2 AMPH TRIO RPS14 APC GRIN2D NR4A1 ITPR3 VAC14 STXBP1 AP1B1 AP2B1 AP1G1 CLTC RAB3B | 9.64e-04 | 886 | 141 | 15 | GO:0098793 |
| GeneOntologyCellularComponent | trans-Golgi network membrane | 9.79e-04 | 112 | 141 | 5 | GO:0032588 | |
| GeneOntologyCellularComponent | Golgi-associated vesicle | 1.06e-03 | 114 | 141 | 5 | GO:0005798 | |
| GeneOntologyCellularComponent | trans-Golgi network | 1.13e-03 | 306 | 141 | 8 | GO:0005802 | |
| GeneOntologyCellularComponent | pyruvate dehydrogenase complex | 1.23e-03 | 8 | 141 | 2 | GO:0045254 | |
| GeneOntologyCellularComponent | myofilament | 1.29e-03 | 32 | 141 | 3 | GO:0036379 | |
| GeneOntologyCellularComponent | clathrin complex | 1.58e-03 | 9 | 141 | 2 | GO:0071439 | |
| GeneOntologyCellularComponent | clathrin-coated pit | 2.11e-03 | 80 | 141 | 4 | GO:0005905 | |
| GeneOntologyCellularComponent | vacuolar membrane | 2.35e-03 | 507 | 141 | 10 | GO:0005774 | |
| GeneOntologyCellularComponent | extrinsic component of plasma membrane | 2.38e-03 | 137 | 141 | 5 | GO:0019897 | |
| GeneOntologyCellularComponent | transport vesicle | 2.78e-03 | 519 | 141 | 10 | GO:0030133 | |
| GeneOntologyCellularComponent | AP-1 adaptor complex | 2.85e-03 | 12 | 141 | 2 | GO:0030121 | |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | GAD2 AMPH CLTCL1 APC IRAK2 ABCC5 DTX3L MAGT1 ARCN1 ITPR3 ARFGEF3 VAC14 AP1B1 AP2B1 AP1G1 BST1 CLTC RAB3B | 3.07e-03 | 1307 | 141 | 18 | GO:0030659 |
| GeneOntologyCellularComponent | spliceosomal complex | 3.42e-03 | 215 | 141 | 6 | GO:0005681 | |
| GeneOntologyCellularComponent | vesicle membrane | GAD2 AMPH CLTCL1 APC IRAK2 ABCC5 DTX3L MAGT1 ARCN1 ITPR3 ARFGEF3 VAC14 AP1B1 AP2B1 AP1G1 BST1 CLTC RAB3B | 3.54e-03 | 1325 | 141 | 18 | GO:0012506 |
| GeneOntologyCellularComponent | glutamatergic synapse | AMPH TRIO HNRNPM APC GRIN2D SLITRK1 ARHGEF15 STXBP1 AP2B1 CLTC NGEF CPEB1 KPNA2 | 3.59e-03 | 817 | 141 | 13 | GO:0098978 |
| GeneOntologyCellularComponent | postsynapse | TRIO NSF HNRNPM RPS14 APC GRIN2D PDPK2P SLITRK1 ARHGEF15 STXBP1 AP2B1 CLTC NGEF CPEB1 KPNA2 | 3.69e-03 | 1018 | 141 | 15 | GO:0098794 |
| GeneOntologyCellularComponent | presynaptic endocytic zone membrane | 3.90e-03 | 14 | 141 | 2 | GO:0098835 | |
| GeneOntologyCellularComponent | lysosomal membrane | 4.18e-03 | 462 | 141 | 9 | GO:0005765 | |
| GeneOntologyCellularComponent | lytic vacuole membrane | 4.18e-03 | 462 | 141 | 9 | GO:0098852 | |
| GeneOntologyCellularComponent | catalytic step 2 spliceosome | 4.23e-03 | 97 | 141 | 4 | GO:0071013 | |
| GeneOntologyCellularComponent | spindle | 4.73e-03 | 471 | 141 | 9 | GO:0005819 | |
| MousePheno | abnormal retinol metabolism | 2.00e-05 | 7 | 118 | 3 | MP:0005444 | |
| Domain | ARM-type_fold | CLTCL1 IPO7 APC ZNFX1 ARFGEF3 VAC14 AP1B1 AP2B1 AP1G1 ARID2 CLTC NCAPD2 KPNA2 | 2.48e-06 | 339 | 145 | 13 | IPR016024 |
| Domain | Clathrin/coatomer_adapt-like_N | 4.45e-06 | 15 | 145 | 4 | IPR002553 | |
| Domain | Adaptin_N | 4.45e-06 | 15 | 145 | 4 | PF01602 | |
| Domain | Alpha_adaptinC2 | 3.72e-05 | 9 | 145 | 3 | PF02883 | |
| Domain | Clathrin_a/b/g-adaptin_app_Ig | 3.72e-05 | 9 | 145 | 3 | IPR008152 | |
| Domain | Alpha_adaptinC2 | 3.72e-05 | 9 | 145 | 3 | SM00809 | |
| Domain | ARM-like | 5.02e-05 | 270 | 145 | 10 | IPR011989 | |
| Domain | Clathrin_H-chain_propeller_rpt | 5.99e-05 | 2 | 145 | 2 | IPR022365 | |
| Domain | Clathrin-link | 5.99e-05 | 2 | 145 | 2 | PF09268 | |
| Domain | - | 5.99e-05 | 2 | 145 | 2 | 2.130.10.110 | |
| Domain | Peptidase_C15 | 5.99e-05 | 2 | 145 | 2 | IPR000816 | |
| Domain | Peptidase_C15-like | 5.99e-05 | 2 | 145 | 2 | IPR016125 | |
| Domain | Clathrin_heavy_chain | 5.99e-05 | 2 | 145 | 2 | IPR016341 | |
| Domain | Peptidase_C15 | 5.99e-05 | 2 | 145 | 2 | PF01470 | |
| Domain | Clathrin_b-adaptin_app_Ig-like | 5.99e-05 | 2 | 145 | 2 | IPR013037 | |
| Domain | PYRASE_CYS | 5.99e-05 | 2 | 145 | 2 | PS01334 | |
| Domain | PYRASE_GLU | 5.99e-05 | 2 | 145 | 2 | PS01333 | |
| Domain | Clathrin_H-chain_propeller_N | 5.99e-05 | 2 | 145 | 2 | IPR001473 | |
| Domain | - | 5.99e-05 | 2 | 145 | 2 | 3.40.630.20 | |
| Domain | tRNA_wybutosine-synth | 5.99e-05 | 2 | 145 | 2 | IPR013917 | |
| Domain | - | 5.99e-05 | 2 | 145 | 2 | 2.60.40.1150 | |
| Domain | Clathrin_H-chain_link/propller | 5.99e-05 | 2 | 145 | 2 | IPR016025 | |
| Domain | Clathrin_propel | 5.99e-05 | 2 | 145 | 2 | PF01394 | |
| Domain | Clathrin_H-chain_linker_core | 5.99e-05 | 2 | 145 | 2 | IPR015348 | |
| Domain | Wyosine_form | 5.99e-05 | 2 | 145 | 2 | PF08608 | |
| Domain | - | NSF DHX40 NTPCR ABCC5 CHD9 ZNFX1 GTPBP1 DNAH7 RAD50 GNAI1 GNAI3 COASY ABCC2 MTREX DDX24 RAB3B SNRNP200 | 6.90e-05 | 746 | 145 | 17 | 3.40.50.300 |
| Domain | Coatomer/clathrin_app_Ig-like | 9.58e-05 | 12 | 145 | 3 | IPR013041 | |
| Domain | THDP-binding | 1.24e-04 | 13 | 145 | 3 | IPR029061 | |
| Domain | - | 1.24e-04 | 13 | 145 | 3 | 3.40.50.970 | |
| Domain | Clathrin_H-chain_linker | 1.79e-04 | 3 | 145 | 2 | IPR012331 | |
| Domain | Nuc_orph_rcpt | 1.79e-04 | 3 | 145 | 2 | IPR003070 | |
| Domain | AP_complex_bsu_1_2_4 | 1.79e-04 | 3 | 145 | 2 | IPR016342 | |
| Domain | B2-adapt-app_C | 1.79e-04 | 3 | 145 | 2 | PF09066 | |
| Domain | CLH | 1.79e-04 | 3 | 145 | 2 | SM00299 | |
| Domain | GDS_CDC24_CS | 2.32e-04 | 39 | 145 | 4 | IPR001331 | |
| Domain | PKS_ER | 2.38e-04 | 16 | 145 | 3 | IPR020843 | |
| Domain | ADH_N | 2.38e-04 | 16 | 145 | 3 | PF08240 | |
| Domain | PKS_ER | 2.38e-04 | 16 | 145 | 3 | SM00829 | |
| Domain | ADH_N | 2.38e-04 | 16 | 145 | 3 | IPR013154 | |
| Domain | ARM | 2.56e-04 | 40 | 145 | 4 | SM00185 | |
| Domain | P-loop_NTPase | NSF DHX40 NTPCR ABCC5 CHD9 ZNFX1 GTPBP1 DNAH7 RAD50 GNAI1 GNAI3 COASY ABCC2 MTREX DDX24 RAB3B SNRNP200 | 3.17e-04 | 848 | 145 | 17 | IPR027417 |
| Domain | - | 3.43e-04 | 18 | 145 | 3 | 3.90.180.10 | |
| Domain | - | 3.47e-04 | 222 | 145 | 8 | 1.25.10.10 | |
| Domain | DNA_pol_B | 3.56e-04 | 4 | 145 | 2 | PF00136 | |
| Domain | B2-adapt-app_C | 3.56e-04 | 4 | 145 | 2 | SM01020 | |
| Domain | DNA-dir_DNA_pol_B | 3.56e-04 | 4 | 145 | 2 | IPR006172 | |
| Domain | DNA-dir_DNA_pol_B_exonuc | 3.56e-04 | 4 | 145 | 2 | IPR006133 | |
| Domain | DNA-dir_DNA_pol_B_multi_dom | 3.56e-04 | 4 | 145 | 2 | IPR006134 | |
| Domain | DNA_pol_B_exo1 | 3.56e-04 | 4 | 145 | 2 | PF03104 | |
| Domain | B-adaptin_app_sub_C | 3.56e-04 | 4 | 145 | 2 | IPR015151 | |
| Domain | POLBc | 3.56e-04 | 4 | 145 | 2 | SM00486 | |
| Domain | ADH_zinc_N | 4.05e-04 | 19 | 145 | 3 | PF00107 | |
| Domain | ADH_SF_Zn-type | 4.05e-04 | 19 | 145 | 3 | IPR002085 | |
| Domain | ADH_C | 4.05e-04 | 19 | 145 | 3 | IPR013149 | |
| Domain | Armadillo | 4.80e-04 | 47 | 145 | 4 | IPR000225 | |
| Domain | AP_beta | 5.89e-04 | 5 | 145 | 2 | IPR026739 | |
| Domain | Transketolase_C | 5.89e-04 | 5 | 145 | 2 | IPR033248 | |
| Domain | Transketolase_fam | 5.89e-04 | 5 | 145 | 2 | IPR033247 | |
| Domain | Transketo_C/PFOR_II | 5.89e-04 | 5 | 145 | 2 | IPR009014 | |
| Domain | Transketolase_C | 5.89e-04 | 5 | 145 | 2 | PF02780 | |
| Domain | - | 5.89e-04 | 5 | 145 | 2 | 3.40.50.920 | |
| Domain | GroES-like | 8.23e-04 | 24 | 145 | 3 | IPR011032 | |
| Domain | Beta2_adaptin/TBP_C_dom | 8.80e-04 | 6 | 145 | 2 | IPR012295 | |
| Domain | - | 8.80e-04 | 6 | 145 | 2 | 3.30.310.10 | |
| Domain | AAA | 9.14e-04 | 144 | 145 | 6 | SM00382 | |
| Domain | AAA+_ATPase | 9.14e-04 | 144 | 145 | 6 | IPR003593 | |
| Domain | Clathrin | 1.23e-03 | 7 | 145 | 2 | PF00637 | |
| Domain | CHCR | 1.23e-03 | 7 | 145 | 2 | PS50236 | |
| Domain | DH_1 | 1.46e-03 | 63 | 145 | 4 | PS00741 | |
| Domain | Helicase_C | 1.48e-03 | 107 | 145 | 5 | PF00271 | |
| Domain | HELICc | 1.48e-03 | 107 | 145 | 5 | SM00490 | |
| Domain | SH3 | 1.51e-03 | 216 | 145 | 7 | SM00326 | |
| Domain | SH3 | 1.51e-03 | 216 | 145 | 7 | PS50002 | |
| Domain | Helicase_C | 1.55e-03 | 108 | 145 | 5 | IPR001650 | |
| Domain | HELICASE_CTER | 1.61e-03 | 109 | 145 | 5 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 1.61e-03 | 109 | 145 | 5 | PS51192 | |
| Domain | DEXDc | 1.61e-03 | 109 | 145 | 5 | SM00487 | |
| Domain | Clathrin_H-chain/VPS_repeat | 1.63e-03 | 8 | 145 | 2 | IPR000547 | |
| Domain | Gprotein_alpha_I | 1.63e-03 | 8 | 145 | 2 | IPR001408 | |
| Domain | Flavodoxin/NO_synth | 1.63e-03 | 8 | 145 | 2 | IPR008254 | |
| Domain | Transketolase-like_Pyr-bd | 1.63e-03 | 8 | 145 | 2 | IPR005475 | |
| Domain | Flavdoxin-like | 1.63e-03 | 8 | 145 | 2 | IPR001094 | |
| Domain | Mss4-like | 1.63e-03 | 8 | 145 | 2 | IPR011057 | |
| Domain | ADH_Zn_CS | 1.63e-03 | 8 | 145 | 2 | IPR002328 | |
| Domain | ADH_ZINC | 1.63e-03 | 8 | 145 | 2 | PS00059 | |
| Domain | Coatomer/calthrin_app_sub_C | 1.63e-03 | 8 | 145 | 2 | IPR009028 | |
| Domain | FLAVODOXIN_LIKE | 1.63e-03 | 8 | 145 | 2 | PS50902 | |
| Domain | Transket_pyr | 1.63e-03 | 8 | 145 | 2 | SM00861 | |
| Domain | Transket_pyr | 1.63e-03 | 8 | 145 | 2 | PF02779 | |
| Domain | Flavodoxin_1 | 1.63e-03 | 8 | 145 | 2 | PF00258 | |
| Domain | SH3_domain | 1.67e-03 | 220 | 145 | 7 | IPR001452 | |
| Domain | Helicase_ATP-bd | 1.68e-03 | 110 | 145 | 5 | IPR014001 | |
| Domain | RhoGEF | 1.93e-03 | 68 | 145 | 4 | SM00325 | |
| Domain | - | 2.07e-03 | 169 | 145 | 6 | 3.40.50.720 | |
| Domain | rSAM | 2.08e-03 | 9 | 145 | 2 | IPR007197 | |
| Domain | Radical_SAM | 2.08e-03 | 9 | 145 | 2 | PF04055 | |
| Domain | RhoGEF | 2.15e-03 | 70 | 145 | 4 | PF00621 | |
| Domain | DH_2 | 2.15e-03 | 70 | 145 | 4 | PS50010 | |
| Domain | - | 2.26e-03 | 71 | 145 | 4 | 1.20.900.10 | |
| Domain | DH-domain | 2.26e-03 | 71 | 145 | 4 | IPR000219 | |
| Pathway | REACTOME_SIGNALING_BY_RETINOIC_ACID | 2.39e-05 | 43 | 114 | 5 | M27443 | |
| Pathway | REACTOME_SIGNALING_BY_RETINOIC_ACID | 4.55e-05 | 49 | 114 | 5 | MM15186 | |
| Pathway | WP_SYNAPTIC_VESICLE_PATHWAY | 5.53e-05 | 51 | 114 | 5 | M39457 | |
| Pathway | REACTOME_G_PROTEIN_MEDIATED_EVENTS | 7.30e-05 | 54 | 114 | 5 | M26911 | |
| Pathway | KEGG_GLYCOLYSIS_GLUCONEOGENESIS | 1.42e-04 | 62 | 114 | 5 | M11521 | |
| Pathway | REACTOME_LYSOSOME_VESICLE_BIOGENESIS | 1.56e-04 | 34 | 114 | 4 | MM15097 | |
| Pathway | REACTOME_SIGNALING_BY_NUCLEAR_RECEPTORS | 1.59e-04 | 191 | 114 | 8 | MM15586 | |
| Pathway | REACTOME_LYSOSOME_VESICLE_BIOGENESIS | 1.75e-04 | 35 | 114 | 4 | M2881 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | 3.12e-04 | 211 | 114 | 8 | MM14502 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | 3.41e-04 | 270 | 114 | 9 | M15514 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | GAD2 NSF GRIN2D SLITRK1 STXBP1 AP2B1 PLCB2 GNAI1 GNAI3 SLITRK6 | 3.84e-04 | 335 | 114 | 10 | MM14503 |
| Pathway | REACTOME_PYRUVATE_METABOLISM | 4.29e-04 | 44 | 114 | 4 | MM15393 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | AMPD2 IPO7 POLA1 MAT2A KRT85 NTPCR HNRNPM RPS14 TACC2 GLOD4 COLGALT1 BIRC6 PGK1 ARCN1 RAD50 AP1B1 AP2B1 AP1G1 FRG1 CLTC NCAPD2 HAGH COASY MTREX DDX24 SNRNP200 HSPA14 KPNA2 | 1.42e-11 | 1415 | 150 | 28 | 28515276 |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | IPO7 MAT2A KRT85 HNRNPM RPS14 RBM28 MAGT1 GTPBP1 SPECC1 CIT PGK1 ARCN1 ITPR3 RAD50 AP2B1 PHF3 FRG1 CLTC GNAI1 GNAI3 MTREX DDX24 SNRNP200 HSPA14 ATP4A KPNA2 | 3.21e-11 | 1257 | 150 | 26 | 36526897 |
| Pubmed | HDAC9 GAD2 TRIO PDHB MAT2A APC ABCC5 CHD9 ZNFX1 BRCC3 VPS54 MED13L KANK2 SPECC1 CIT PGK1 ARCN1 STXBP1 RPRD1A AP2B1 CLTC NGEF ANKRD36 QKI SNRNP200 | 2.89e-10 | 1285 | 150 | 25 | 35914814 | |
| Pubmed | IPO7 NSF PDHB POLA1 MAT2A NTPCR HNRNPM ARCN1 RAD50 RPRD1A AP1B1 AP2B1 AP1G1 CLTC NCAPD2 MTREX SNRNP200 KPNA2 | 3.69e-10 | 638 | 150 | 18 | 33239621 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | TPT1 AMPD2 NSF PDHB MAT2A HNRNPM RPS14 BRCC3 GLOD4 MAGT1 GTPBP1 PGK1 ARCN1 RAD50 RMDN3 AP1B1 AP1G1 CLTC NCAPD2 GNAI1 HAGH GNAI3 QKI DDX24 KPNA2 | 1.03e-09 | 1367 | 150 | 25 | 32687490 |
| Pubmed | TPT1 IPO7 MAT2A NTPCR CHD9 RBM28 MED13L GTPBP1 CIT LSM5 PGK1 RAD50 KANSL3 AP1B1 AP2B1 ARID2 FRG1 CLTC MTREX QKI SNRNP200 RASGRP2 | 2.42e-09 | 1103 | 150 | 22 | 34189442 | |
| Pubmed | IPO7 POLA1 POLE RPS14 RBM28 BIRC6 PGK1 ITPR3 RAD50 AP1B1 AP2B1 PHF3 CLTC NCAPD2 MTREX DDX24 SNRNP200 | 3.89e-09 | 653 | 150 | 17 | 22586326 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | IPO7 PDHB POLA1 DHX40 MAT2A POLE HNRNPM RPS14 RBM28 COLGALT1 PHF8 BIRC6 CXXC1 PGK1 ARCN1 RAD50 AP2B1 AP1G1 CLTC NCAPD2 ANKIB1 MTREX DDX24 SNRNP200 | 4.19e-09 | 1353 | 150 | 24 | 29467282 |
| Pubmed | IPO7 PDHA2 NSF PDHB MAT2A HNRNPM RPS14 APC CHD9 MED13L SPECC1 CIT PGK1 ARCN1 ITPR3 AP2B1 PHF3 CLTC GNAI1 GNAI3 MTREX DDX24 KPNA2 | 4.43e-09 | 1247 | 150 | 23 | 27684187 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | PDHB POLE HNRNPM BCKDHB TACC2 RBM28 PHF8 GTPBP1 BIRC6 ARCN1 PHF3 ARID2 FRG1 MTREX DDX24 SNRNP200 HSPA14 KPNA2 | 5.62e-09 | 759 | 150 | 18 | 35915203 |
| Pubmed | CLTCL1 IPO7 NTPCR HNRNPM RPS14 MAGT1 COLGALT1 GTPBP1 BIRC6 CIT PGK1 ARCN1 ITPR3 RAD50 AP2B1 AP1G1 CLTC NCAPD2 GNAI3 DDX24 HSPA14 KPNA2 | 6.83e-09 | 1168 | 150 | 22 | 19946888 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | IPO7 TRIO NSF PDHB POLA1 MAT2A POLE HNRNPM RPS14 GLOD4 COLGALT1 GTPBP1 PGK1 ARCN1 RAD50 RPRD1A AP1G1 CLTC NCAPD2 COASY MTREX DDX24 SNRNP200 KPNA2 | 1.13e-08 | 1425 | 150 | 24 | 30948266 |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | PDHB POLA1 POLE NTPCR HNRNPM RPS14 BIRC6 ARCN1 RAD50 STXBP1 AP1G1 CLTC GNAI3 MTREX DDX24 SNRNP200 HSPA14 | 1.18e-08 | 704 | 150 | 17 | 29955894 |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | AMPD2 IPO7 NSF POLE HNRNPM MAGT1 ARCN1 ITPR3 ARFGEF3 RMDN3 VAC14 RPRD1A AP1B1 AP1G1 CLTC NCAPD2 QKI HSPA14 KPNA2 | 2.75e-08 | 942 | 150 | 19 | 31073040 |
| Pubmed | CLTCL1 NSF MAT2A HNRNPM RPS14 CHD9 PHF8 LSM5 DNAH7 PGK1 ARCN1 AP1B1 AP2B1 FRG1 CLTC NCAPD2 MTREX RAB3B SNRNP200 ATP4A KPNA2 | 2.77e-08 | 1153 | 150 | 21 | 29845934 | |
| Pubmed | Clint: a novel clathrin-binding ENTH-domain protein at the Golgi. | 4.12e-08 | 9 | 150 | 4 | 12429846 | |
| Pubmed | 4.12e-08 | 163 | 150 | 9 | 16512683 | ||
| Pubmed | AMPH TRIO NSF PDHB HNRNPM RPS14 APC ZNFX1 GTPBP1 KANK2 SPECC1 CIT PGK1 ARCN1 STXBP1 AP1B1 AP2B1 AP1G1 CLTC NGEF FBXO41 GNAI1 SNRNP200 | 5.55e-08 | 1431 | 150 | 23 | 37142655 | |
| Pubmed | Functional equivalence of the clathrin heavy chains CHC17 and CHC22 in endocytosis and mitosis. | 7.86e-08 | 3 | 150 | 3 | 19509056 | |
| Pubmed | AMPD2 TRIO NSF HNRNPM APC ZNFX1 GRIN2D KANK2 CIT PGK1 RAD50 AP1B1 AP2B1 CLTC NGEF FBXO41 GNAI1 RAB3B | 2.02e-07 | 963 | 150 | 18 | 28671696 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | IPO7 NSF PDHB DHX40 MAT2A POLE BRCC3 RBM28 KANK2 ITPR3 RAD50 RMDN3 AP1B1 AP2B1 GNAI1 GNAI3 QKI SNRNP200 | 2.39e-07 | 974 | 150 | 18 | 28675297 |
| Pubmed | RIM-BP3 is a manchette-associated protein essential for spermiogenesis. | 3.14e-07 | 4 | 150 | 3 | 19091768 | |
| Pubmed | IPO7 PDHA2 PDHB DHX40 MAT2A NTPCR HNRNPM RPS14 BRCC3 COLGALT1 GTPBP1 RAD50 RPRD1A AP1B1 AP2B1 CLTC MTREX DDX24 SNRNP200 HSPA14 KPNA2 | 3.18e-07 | 1335 | 150 | 21 | 29229926 | |
| Pubmed | Plk2 attachment to NSF induces homeostatic removal of GluA2 during chronic overexcitation. | 3.22e-07 | 14 | 150 | 4 | 20802490 | |
| Pubmed | Repression of rRNA transcription by PARIS contributes to Parkinson's disease. | PDHB NTPCR HNRNPM RBM28 PGK1 AP1G1 ZNF746 CLTC MTREX SNRNP200 | 3.25e-07 | 272 | 150 | 10 | 25315684 |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | 4.37e-07 | 281 | 150 | 10 | 28706196 | |
| Pubmed | IPO7 DHX40 POLE NTPCR NR4A3 ZNFX1 NEB DNAH7 ITPR3 ANKRD36B STXBP1 AP1B1 ARID2 LMOD1 | 7.71e-07 | 638 | 150 | 14 | 31182584 | |
| Pubmed | Structure and evolution of RIM-BP genes: identification of a novel family member. | 7.81e-07 | 5 | 150 | 3 | 17855024 | |
| Pubmed | Novel binding sites on clathrin and adaptors regulate distinct aspects of coat assembly. | 7.81e-07 | 5 | 150 | 3 | 17052248 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | HNRNPM RPS14 BRCC3 RBM28 MAGT1 NR4A1 PHF8 LSM5 CXXC1 ITPR3 RAD50 KANSL3 INTS14 ZSCAN30 PHF3 FRG1 MTREX DDX24 SNRNP200 KPNA2 | 8.20e-07 | 1294 | 150 | 20 | 30804502 |
| Pubmed | 8.83e-07 | 234 | 150 | 9 | 36243803 | ||
| Pubmed | TRIO POLA1 DHX40 KRT85 COLGALT1 KANK2 RAD50 KANSL3 AP2B1 AP1G1 PHF3 ARID2 | 1.08e-06 | 472 | 150 | 12 | 38943005 | |
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | IPO7 NSF PDHB MAT2A RPS14 GTPBP1 PGK1 ARCN1 STXBP1 AP1B1 AP2B1 DDX24 SNRNP200 KPNA2 | 1.25e-06 | 665 | 150 | 14 | 30457570 |
| Pubmed | 1.56e-06 | 6 | 150 | 3 | 10748223 | ||
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | POLA1 HNRNPM PGK1 RAD50 PHF3 ARID2 CLTC NCAPD2 SNRNP200 KPNA2 | 1.97e-06 | 332 | 150 | 10 | 32786267 |
| Pubmed | IPO7 BRCC3 RBM28 MAGT1 GTPBP1 PGK1 ARCN1 FABP1 ANKRD36B KANSL3 AP1B1 AP2B1 PHF3 FRG1 CLTC HAGH GNAI3 MTREX QKI HSPA14 | 1.98e-06 | 1371 | 150 | 20 | 36244648 | |
| Pubmed | IPO7 HNRNPM RPS14 RBM28 MAGT1 COLGALT1 KANK2 ARCN1 RAD50 AP2B1 AP1G1 CLTC SNRNP200 | 2.28e-06 | 601 | 150 | 13 | 33658012 | |
| Pubmed | POLA1 NTPCR HNRNPM DTX3L RAD50 AP1B1 AP2B1 CLTC MTREX SNRNP200 | 2.44e-06 | 340 | 150 | 10 | 24332808 | |
| Pubmed | IPO7 PDHB DHX40 MAT2A HNRNPM RPS14 APC CHD9 SPECC1 ARCN1 INTS14 CLTC NCAPD2 SNRNP200 KPNA2 | 2.46e-06 | 809 | 150 | 15 | 32129710 | |
| Pubmed | Clathrin interacts specifically with amphiphysin and is displaced by dynamin. | 2.72e-06 | 7 | 150 | 3 | 9280305 | |
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | NSF PDHB DHX40 MAT2A HNRNPM RPS14 PGK1 ARCN1 STXBP1 CLTC MTREX DDX24 SNRNP200 KPNA2 | 2.86e-06 | 714 | 150 | 14 | 28302793 |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 2.93e-06 | 202 | 150 | 8 | 33005030 | |
| Pubmed | 3.08e-06 | 52 | 150 | 5 | 20114047 | ||
| Pubmed | IPO7 NSF PDHB MAT2A POLE NTPCR HNRNPM RPS14 COLGALT1 PHF8 GTPBP1 CLTC SNRNP200 KPNA2 | 3.41e-06 | 725 | 150 | 14 | 27025967 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | ERCC4 HNRNPM APC RBM28 ITPR3 RPRD1A PHF3 ARID2 CLTC MTREX KPNA2 | 3.62e-06 | 440 | 150 | 11 | 34244565 |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | DHRS3 POLA1 HNRNPM COQ8B RPS14 RBM28 PHF8 BIRC6 CXXC1 ARCN1 CLTC EEF1AKMT1 SNRNP200 FBXO34 | 4.05e-06 | 736 | 150 | 14 | 29676528 |
| Pubmed | TRIO BMP2K NSF HNRNPM BRCC3 RBM28 SPECC1 ITPR3 AP2B1 ARID2 CLTC MTREX DDX24 | 4.07e-06 | 634 | 150 | 13 | 34591612 | |
| Pubmed | 4.16e-06 | 97 | 150 | 6 | 22360420 | ||
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | TPT1 CLTCL1 MAT2A RPS14 BRCC3 RBM28 CIT PGK1 ARCN1 RAD50 AP1B1 AP2B1 CLTC NCAPD2 SNRNP200 | 4.29e-06 | 847 | 150 | 15 | 35235311 |
| Pubmed | 4.32e-06 | 284 | 150 | 9 | 29459677 | ||
| Pubmed | CCT3 acts upstream of YAP and TFCP2 as a potential target and tumour biomarker in liver cancer. | 4.84e-06 | 288 | 150 | 9 | 31501420 | |
| Pubmed | IPO7 TENT4A NSF HNRNPM RBM28 MAGT1 ARCN1 VAC14 AP1B1 AP2B1 AP1G1 FRG1 MTREX | 5.59e-06 | 653 | 150 | 13 | 33742100 | |
| Pubmed | Maternal bile acid transporter deficiency promotes neonatal demise. | 5.79e-06 | 59 | 150 | 5 | 26416771 | |
| Pubmed | Functional genomics identifies therapeutic targets for MYC-driven cancer. | 5.90e-06 | 103 | 150 | 6 | 22623531 | |
| Pubmed | IPO7 PDHB RAD50 INTS14 AP1B1 AP2B1 AP1G1 CLTC NCAPD2 MTREX DDX24 SNRNP200 | 6.23e-06 | 560 | 150 | 12 | 35241646 | |
| Pubmed | EpsinR: an AP1/clathrin interacting protein involved in vesicle trafficking. | 6.48e-06 | 9 | 150 | 3 | 12538641 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | BMP2K PDHB POLE NTPCR COQ8B RPS14 RTN4IP1 TACC2 RBM28 MAGT1 BIRC6 ITPR3 ARFGEF3 RMDN3 VPS13D ARID2 CLTC QKI DDX24 RAB3B | 7.27e-06 | 1496 | 150 | 20 | 32877691 |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | IPO7 NSF POLA1 DHX40 KRT85 APC BRCC3 KLHL20 ARCN1 FABP4 RAD50 AP2B1 FRG1 QKI DDX24 SNRNP200 | 7.74e-06 | 1005 | 150 | 16 | 19615732 |
| Pubmed | METTL3 protects METTL14 from STUB1-mediated degradation to maintain m6 A homeostasis. | 7.85e-06 | 231 | 150 | 8 | 36597993 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | IPO7 NSF POLE HNRNPM GTPBP1 ARCN1 RAD50 AP1B1 NCAPD2 MTREX SNRNP200 KPNA2 | 9.16e-06 | 582 | 150 | 12 | 20467437 |
| Pubmed | GAD2 AMPD2 AMPH TRIO PDHB HNRNPM APC ZNFX1 TACC2 BIRC6 CIT PGK1 ARCN1 ARFGEF3 STXBP1 CLTC FBXO41 | 9.20e-06 | 1139 | 150 | 17 | 36417873 | |
| Pubmed | 9.23e-06 | 10 | 150 | 3 | 25898166 | ||
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | IPO7 NSF PDHB MAT2A HNRNPM RPS14 PGK1 ARCN1 RAD50 VAC14 AP1B1 AP2B1 CLTC NCAPD2 HAGH SNRNP200 KPNA2 | 1.03e-05 | 1149 | 150 | 17 | 35446349 |
| Pubmed | 1.08e-05 | 403 | 150 | 10 | 30562941 | ||
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | APC TACC2 KANK2 SPECC1 PGK1 ARCN1 KANSL3 RMDN3 FBXO5 AP2B1 ARID2 CLTC GNAI1 GNAI3 TEN1 SNRNP200 KPNA2 | 1.10e-05 | 1155 | 150 | 17 | 20360068 |
| Pubmed | CLTCL1 POLA1 MAT2A AP1B1 AP2B1 CLTC NCAPD2 GNAI1 GNAI3 HSPA14 | 1.28e-05 | 411 | 150 | 10 | 36652389 | |
| Pubmed | BMP2K PDHB NTPCR HNRNPM RPS14 KANK2 PGK1 AP2B1 CLTC GNAI3 QKI SNRNP200 KPNA2 | 1.30e-05 | 707 | 150 | 13 | 19738201 | |
| Pubmed | IPO7 NSF MAT2A HNRNPM RPS14 APC ABCC5 MAGT1 ARCN1 FBXO5 NCAPD2 SNRNP200 KPNA2 | 1.32e-05 | 708 | 150 | 13 | 39231216 | |
| Pubmed | PDHB MAT2A HNRNPM RPS14 ZNFX1 GTPBP1 LSM5 ARCN1 ITPR3 CLTC GNAI3 COASY SNRNP200 | 1.38e-05 | 711 | 150 | 13 | 33022573 | |
| Pubmed | CLTCL1 IPO7 BMP2K NSF COQ8B RBM28 COLGALT1 SPECC1 ARCN1 ITPR3 RAD50 ARFGEF3 AP2B1 CLTC NCAPD2 MTREX DDX24 SNRNP200 KPNA2 | 1.51e-05 | 1440 | 150 | 19 | 30833792 | |
| Pubmed | TPT1 CLTCL1 PDHB HNRNPM ABCC5 NEB CXXC1 PGK1 SCML4 STXBP1 AP2B1 CLTC NCAPD2 GNAI1 MYOM2 GNAI3 ABCC2 CEP57 RAB3B | 1.54e-05 | 1442 | 150 | 19 | 35575683 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | BMP2K NSF PDHB MAT2A HNRNPM RPS14 BCKDHB RBM28 MAGT1 GTPBP1 ARCN1 KANSL3 FRG1 CLTC MTREX DDX24 SNRNP200 KPNA2 | 1.63e-05 | 1318 | 150 | 18 | 30463901 |
| Pubmed | Multi-omics profiling identifies a deregulated FUS-MAP1B axis in ALS/FTD-associated UBQLN2 mutants. | 1.65e-05 | 256 | 150 | 8 | 35777956 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | AMPD2 IPO7 PDHB POLA1 MAT2A HNRNPM RPS14 BRCC3 BIRC6 ARCN1 RPRD1A AP1B1 AP2B1 AP1G1 NCAPD2 GNAI3 COASY SNRNP200 KPNA2 | 1.74e-05 | 1455 | 150 | 19 | 22863883 |
| Pubmed | Network organization of the huntingtin proteomic interactome in mammalian brain. | AMPH IPO7 BMP2K NSF PDHB STXBP1 AP1B1 AP2B1 AP1G1 GNAI3 RAB3B ATP4A | 1.74e-05 | 621 | 150 | 12 | 22794259 |
| Pubmed | The orphan nuclear receptor Nor1/Nr4a3 is a negative regulator of β-cell mass. | 1.85e-05 | 2 | 150 | 2 | 30696767 | |
| Pubmed | NR4A3 Suppresses Lymphomagenesis through Induction of Proapoptotic Genes. | 1.85e-05 | 2 | 150 | 2 | 28249906 | |
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 20668010 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 11303599 | ||
| Pubmed | The nuclear orphan receptor NR4A1 and NR4A3 as tumor suppressors in hematologic neoplasms. | 1.85e-05 | 2 | 150 | 2 | 25410408 | |
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 11451993 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 17360709 | ||
| Pubmed | Abrogation of nuclear receptors Nr4a3 and Nr4a1 leads to development of acute myeloid leukemia. | 1.85e-05 | 2 | 150 | 2 | 17515897 | |
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 23326512 | ||
| Pubmed | Reduced NR4A gene dosage leads to mixed myelodysplastic/myeloproliferative neoplasms in mice. | 1.85e-05 | 2 | 150 | 2 | 21205929 | |
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 33754034 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 29472232 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 33674745 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 8733129 | ||
| Pubmed | Intracellular fatty acid-binding proteins: putting lower vertebrates in perspective. | 1.85e-05 | 2 | 150 | 2 | 9070383 | |
| Pubmed | Fatty acids in cell signalling: modulation by lipid binding proteins. | 1.85e-05 | 2 | 150 | 2 | 7784447 | |
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 16162496 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 20411565 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 29097553 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 19153266 | ||
| Pubmed | The clathrin heavy chain isoform CHC22 functions in a novel endosomal sorting step. | 1.85e-05 | 2 | 150 | 2 | 20065094 | |
| Pubmed | The human genome encodes at least three non-allellic G proteins with alpha i-type subunits. | 1.85e-05 | 2 | 150 | 2 | 2440724 | |
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 23247046 | ||
| Pubmed | Spindle Assembly Disruption and Cancer Cell Apoptosis with a CLTC-Binding Compound. | 1.85e-05 | 2 | 150 | 2 | 29769406 | |
| Pubmed | The p97/VCP segregase is essential for arsenic-induced degradation of PML and PML-RARA. | 1.95e-05 | 262 | 150 | 8 | 36880596 | |
| Interaction | CEBPA interactions | TPT1 IPO7 MAT2A NTPCR HNRNPM RPS14 CHD9 RBM28 MED13L GTPBP1 CIT LSM5 PGK1 FABP4 RAD50 KANSL3 AP1B1 AP2B1 ARID2 FRG1 CLTC MTREX QKI SNRNP200 RASGRP2 | 4.61e-06 | 1245 | 149 | 25 | int:CEBPA |
| Interaction | EED interactions | TPT1 IPO7 TRIO BMP2K NSF HNRNPM RPS14 PSPH RBM28 MAGT1 COLGALT1 BIRC6 CIT LSM5 PGK1 ARCN1 RAD50 INTS14 AP2B1 AP1G1 FRG1 CLTC NCAPD2 MTREX DDX24 SNRNP200 KPNA2 | 6.89e-06 | 1445 | 149 | 27 | int:EED |
| Interaction | EFTUD2 interactions | AMPD2 IPO7 POLA1 MAT2A NTPCR HNRNPM RPS14 TACC2 GLOD4 COLGALT1 BIRC6 CIT ARCN1 RAD50 AP1B1 AP2B1 AP1G1 FRG1 ZNF746 CLTC NCAPD2 COASY MTREX DDX24 SNRNP200 HSPA14 KPNA2 | 7.24e-06 | 1449 | 149 | 27 | int:EFTUD2 |
| Interaction | HECTD1 interactions | IPO7 PDHB POLE HNRNPM APC BCKDHB TACC2 RBM28 PHF8 GTPBP1 BIRC6 ARCN1 PHF3 ARID2 FRG1 NCAPD2 MTREX DDX24 SNRNP200 HSPA14 KPNA2 | 1.18e-05 | 984 | 149 | 21 | int:HECTD1 |
| Interaction | STIP1 interactions | IPO7 NSF PDHB POLA1 MAT2A NTPCR HNRNPM NEB PGK1 ARCN1 RAD50 RPRD1A AP1B1 AP2B1 AP1G1 CLTC NCAPD2 MTREX SNRNP200 HSPA14 KPNA2 | 1.65e-05 | 1006 | 149 | 21 | int:STIP1 |
| Interaction | AP2B1 interactions | AMPH BMP2K APC KANK2 CIT CFAP54 AP1B1 AP2B1 AP1G1 CLTC DDX24 KPNA2 | 2.21e-05 | 373 | 149 | 12 | int:AP2B1 |
| Interaction | NECAP1 interactions | 2.45e-05 | 78 | 149 | 6 | int:NECAP1 | |
| Interaction | PPIA interactions | TRIO POLA1 DHX40 KRT85 HNRNPM RPS14 ANKRD36C COLGALT1 KANK2 CIT RAD50 KANSL3 AP2B1 AP1G1 PHF3 ARID2 ANKRD36 HAGH COASY | 3.10e-05 | 888 | 149 | 19 | int:PPIA |
| Interaction | SIRT7 interactions | IPO7 POLA1 POLE RPS14 RBM28 BIRC6 PGK1 ITPR3 RAD50 AP1B1 AP2B1 PHF3 CLTC NCAPD2 MTREX DDX24 SNRNP200 | 3.71e-05 | 744 | 149 | 17 | int:SIRT7 |
| Interaction | WNK3 interactions | 5.82e-05 | 56 | 149 | 5 | int:WNK3 | |
| Interaction | ANKIB1 interactions | 6.26e-05 | 11 | 149 | 3 | int:ANKIB1 | |
| Interaction | CDC5L interactions | IPO7 TRIO NSF DHX40 HNRNPM GTPBP1 KANK2 CIT ARCN1 RAD50 AP1B1 FRG1 ZNF746 NCAPD2 MAP3K13 MTREX SNRNP200 KPNA2 | 6.26e-05 | 855 | 149 | 18 | int:CDC5L |
| Interaction | LMBR1L interactions | AMPD2 IPO7 NSF POLE HNRNPM MAGT1 ARCN1 ITPR3 ARFGEF3 RMDN3 VAC14 RPRD1A AP1B1 AP1G1 CLTC NCAPD2 QKI HSPA14 KPNA2 | 7.23e-05 | 946 | 149 | 19 | int:LMBR1L |
| Interaction | AFTPH interactions | 7.50e-05 | 59 | 149 | 5 | int:AFTPH | |
| Interaction | TRIM28 interactions | TPT1 IPO7 PDHB POLA1 POLE MTSS1 NTPCR HNRNPM RPS14 NR4A3 BRCC3 NR4A1 BIRC6 CIT ARCN1 RAD50 STXBP1 AP1G1 ZNF746 CLTC GNAI3 MTREX DDX24 SNRNP200 HSPA14 | 7.83e-05 | 1474 | 149 | 25 | int:TRIM28 |
| Interaction | KCNA3 interactions | IPO7 NSF MAT2A HNRNPM RPS14 APC ABCC5 CHD9 MAGT1 SPECC1 ARCN1 FABP4 RAD50 FBXO5 PHF3 NCAPD2 SNRNP200 KPNA2 | 7.93e-05 | 871 | 149 | 18 | int:KCNA3 |
| Interaction | RANBP2 interactions | TPT1 HNRNPM RPS14 APC CIT ITPR3 RAD50 ZNF746 CLTC SNRNP200 KPNA2 | 7.98e-05 | 361 | 149 | 11 | int:RANBP2 |
| Interaction | EP300 interactions | CLTCL1 IPO7 TENT4A NSF HNRNPM NR4A3 TACC2 RBM28 MAGT1 NR4A1 BIRC6 CXXC1 ARCN1 RAD50 VAC14 AP1B1 AP2B1 AP1G1 FRG1 CLTC MTREX DDX24 SNRNP200 KPNA2 | 9.52e-05 | 1401 | 149 | 24 | int:EP300 |
| Interaction | EXOSC3 interactions | 9.94e-05 | 100 | 149 | 6 | int:EXOSC3 | |
| Interaction | NECAP2 interactions | 1.03e-04 | 63 | 149 | 5 | int:NECAP2 | |
| Interaction | NR3C1 interactions | IPO7 PDHB DHX40 POLE NTPCR CHD9 NR4A3 ZNFX1 BRCC3 NR4A1 NEB DNAH7 ITPR3 ANKRD36B STXBP1 AP1B1 ARID2 LMOD1 KPNA2 | 1.06e-04 | 974 | 149 | 19 | int:NR3C1 |
| Interaction | RFXANK interactions | 1.08e-04 | 146 | 149 | 7 | int:RFXANK | |
| Interaction | DNAJC6 interactions | 1.11e-04 | 64 | 149 | 5 | int:DNAJC6 | |
| Interaction | RALBP1 interactions | 1.15e-04 | 198 | 149 | 8 | int:RALBP1 | |
| Interaction | AP1G1 interactions | 1.28e-04 | 150 | 149 | 7 | int:AP1G1 | |
| Interaction | SUMO2 interactions | HDAC9 ERCC4 POLA1 HNRNPM BRCC3 PHF8 PGK1 RAD50 PHF3 ARID2 CLTC NCAPD2 SNRNP200 KPNA2 | 1.28e-04 | 591 | 149 | 14 | int:SUMO2 |
| Interaction | BRCA1 interactions | ERCC4 IPO7 TRIO NSF DHX40 POLE HNRNPM RPS14 CHD9 BRCC3 RBM28 CIT PGK1 RAD50 RPRD1A FBXO5 AP2B1 CLTC DDX24 SNRNP200 HSPA14 KPNA2 | 1.30e-04 | 1249 | 149 | 22 | int:BRCA1 |
| Interaction | DDRGK1 interactions | IPO7 NTPCR HNRNPM RPS14 RBM28 MAGT1 PHF8 GTPBP1 SPECC1 ARCN1 RMDN3 VAC14 AP2B1 FRG1 CLTC GNAI1 MTREX QKI DDX24 RAB3B SNRNP200 KPNA2 | 1.30e-04 | 1249 | 149 | 22 | int:DDRGK1 |
| Interaction | LRRC31 interactions | 1.46e-04 | 205 | 149 | 8 | int:LRRC31 | |
| Interaction | ZNF746 interactions | PDHB NTPCR HNRNPM RBM28 PGK1 AP1G1 ZNF746 CLTC MTREX SNRNP200 | 1.60e-04 | 326 | 149 | 10 | int:ZNF746 |
| Interaction | PLK2 interactions | 1.70e-04 | 70 | 149 | 5 | int:PLK2 | |
| Interaction | SNAP91 interactions | 1.70e-04 | 70 | 149 | 5 | int:SNAP91 | |
| Interaction | H1-5 interactions | IPO7 RPS14 ABCC5 PIWIL4 RBM28 ACSF2 PHF8 CIT ARHGEF15 ANKRD36B PHF3 DDX24 | 1.74e-04 | 463 | 149 | 12 | int:H1-5 |
| Interaction | GNMT interactions | 1.93e-04 | 39 | 149 | 4 | int:GNMT | |
| Interaction | AMPH interactions | 1.94e-04 | 72 | 149 | 5 | int:AMPH | |
| Interaction | HNRNPCL2 interactions | 2.07e-04 | 274 | 149 | 9 | int:HNRNPCL2 | |
| Interaction | ARHGAP18 interactions | 2.14e-04 | 115 | 149 | 6 | int:ARHGAP18 | |
| Interaction | HNRNPU interactions | AMPD2 CLTCL1 PDHA2 HNRNPM RPS14 CHD9 GRIN2D RBM28 PHF8 BIRC6 CIT FRG1 NCAPD2 MTREX DDX24 CEP57 SNRNP200 FBXO34 KPNA2 | 2.31e-04 | 1035 | 149 | 19 | int:HNRNPU |
| Interaction | KCTD13 interactions | AMPH TRIO NSF PDHB HNRNPM RPS14 APC ZNFX1 GTPBP1 KANK2 SPECC1 CIT PGK1 ARCN1 STXBP1 AP1B1 AP2B1 AP1G1 CLTC NGEF FBXO41 GNAI1 SNRNP200 | 2.34e-04 | 1394 | 149 | 23 | int:KCTD13 |
| Interaction | SIRT6 interactions | ERCC4 HNRNPM APC RBM28 ITPR3 RAD50 RPRD1A PHF3 ARID2 CLTC NCAPD2 MTREX SNRNP200 KPNA2 | 2.40e-04 | 628 | 149 | 14 | int:SIRT6 |
| Interaction | ATXN1 interactions | IPO7 NSF PDHB MAT2A RPS14 PSPH MAGT1 NR4A1 GTPBP1 PGK1 ARCN1 STXBP1 AP1B1 AP2B1 MYOM2 QKI DDX24 SNRNP200 KPNA2 | 2.43e-04 | 1039 | 149 | 19 | int:ATXN1 |
| Interaction | CLTA interactions | 2.90e-04 | 351 | 149 | 10 | int:CLTA | |
| Interaction | MTF1 interactions | 3.08e-04 | 123 | 149 | 6 | int:MTF1 | |
| Interaction | PRC1 interactions | BDP1 AMPD2 CLTCL1 PDHB MAT2A HNRNPM RPS14 APC TACC2 GLOD4 RBM28 GTPBP1 SPECC1 CIT CLTC GNAI1 SNRNP200 KPNA2 | 3.11e-04 | 973 | 149 | 18 | int:PRC1 |
| Interaction | CHMP4B interactions | AMPD2 CLTCL1 IPO7 PDHB HNRNPM RPS14 SPECC1 CIT ITPR3 FBXO5 CLTC GNAI1 GNAI3 SNRNP200 KPNA2 | 3.28e-04 | 727 | 149 | 15 | int:CHMP4B |
| Interaction | SLX4 interactions | ERCC4 IPO7 DHX40 HNRNPM CHD9 PHF8 SPECC1 RAD50 AP1B1 AP2B1 CLTC SNRNP200 KPNA2 | 3.35e-04 | 572 | 149 | 13 | int:SLX4 |
| Interaction | CAND1 interactions | CLTCL1 IPO7 PDHA2 PDHB HNRNPM RPS14 BRCC3 RBM28 GTPBP1 FRG1 ZNF746 CLTC NGEF MTREX DDX24 SNRNP200 KPNA2 | 3.37e-04 | 894 | 149 | 17 | int:CAND1 |
| Interaction | CIB2 interactions | 3.37e-04 | 81 | 149 | 5 | int:CIB2 | |
| Interaction | PIH1D1 interactions | AMPD2 IPO7 MAT2A HNRNPM RPS14 TACC2 GLOD4 BIRC6 PGK1 RAD50 RPRD1A CLTC HAGH COASY SNRNP200 | 3.47e-04 | 731 | 149 | 15 | int:PIH1D1 |
| Interaction | AP1S3 interactions | 3.52e-04 | 19 | 149 | 3 | int:AP1S3 | |
| Interaction | WDHD1 interactions | 3.52e-04 | 177 | 149 | 7 | int:WDHD1 | |
| Interaction | LIMA1 interactions | TPT1 CLTCL1 IPO7 BMP2K POLA1 SPECC1 CIT ITPR3 AP2B1 CLTC DDX24 | 3.56e-04 | 429 | 149 | 11 | int:LIMA1 |
| Interaction | AP2M1 interactions | AMPH BMP2K MAT2A APC CIT AP1B1 AP2B1 AP1G1 ZNF746 CLTC ABCC2 | 3.63e-04 | 430 | 149 | 11 | int:AP2M1 |
| Interaction | CLTC interactions | AMPH CLTCL1 BMP2K HNRNPM GRIN2D COLGALT1 CIT AP1B1 AP2B1 AP1G1 ZNF746 CLTC ABCC2 ATP4A | 3.67e-04 | 655 | 149 | 14 | int:CLTC |
| Cytoband | 2q11.2 | 9.48e-05 | 72 | 150 | 4 | 2q11.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q11 | 1.54e-04 | 153 | 150 | 5 | chr2q11 | |
| Cytoband | 22q11.21 | 5.00e-04 | 111 | 150 | 4 | 22q11.21 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 1.97e-04 | 181 | 84 | 6 | 694 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 2.51e-04 | 66 | 84 | 4 | 722 | |
| GeneFamily | Alcohol dehydrogenases | 5.86e-04 | 8 | 84 | 2 | 397 | |
| GeneFamily | Cyclins|F-boxes other | 7.84e-04 | 39 | 84 | 3 | 560 | |
| GeneFamily | X-linked mental retardation|RNA helicases | 1.14e-03 | 11 | 84 | 2 | 1168 | |
| GeneFamily | ATP binding cassette subfamily C | 1.61e-03 | 13 | 84 | 2 | 807 | |
| GeneFamily | Fatty acid binding protein family | 2.45e-03 | 16 | 84 | 2 | 550 | |
| GeneFamily | Armadillo repeat containing|Importins | 3.11e-03 | 18 | 84 | 2 | 596 | |
| GeneFamily | DNA polymerases | 5.06e-03 | 23 | 84 | 2 | 535 | |
| GeneFamily | Ankyrin repeat domain containing | 5.40e-03 | 242 | 84 | 5 | 403 | |
| Coexpression | BROWNE_HCMV_INFECTION_2HR_UP | 3.21e-06 | 40 | 150 | 5 | M3649 | |
| Coexpression | XIE_TRASTUZUMAB_CARDIOTOXICITY_MMU_MIR_708_5P_GENES | 8.94e-06 | 49 | 150 | 5 | MM17508 | |
| Coexpression | GSE10273_LOW_IL7_VS_HIGH_IL7_AND_IRF4_IN_IRF4_8_NULL_PRE_BCELL_DN | 2.08e-05 | 200 | 150 | 8 | M322 | |
| Coexpression | GSE30962_PRIMARY_VS_SECONDARY_ACUTE_LCMV_INF_CD8_TCELL_UP | 2.08e-05 | 200 | 150 | 8 | M5041 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_anti-infl-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.06e-07 | 200 | 150 | 8 | 74ceebee9af63f8b3ec5857eff1b662752bc3862 | |
| ToppCell | LPS-IL1RA-Endothelial-Epi-like-Alv_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.47e-07 | 138 | 150 | 7 | 5f8ac8f67e34a7cf560099208e6884102532391e | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-Microglia/Mac|metastatic_Lymph_Node / Location, Cell class and cell subclass | 1.96e-06 | 172 | 150 | 7 | f673a2e697b46e7cfa4186cb3fb2b98e3c83703e | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Epithelial_transtional-epithelial_cell_of_lung-Transitional_Club-AT2-Transitional_Club-AT2_L.0.4.1.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.20e-06 | 175 | 150 | 7 | dbd9dac129fb6ae5f55e7b96d04b37585458dc4a | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-alveolar_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.75e-06 | 181 | 150 | 7 | 8fcdab61fad2efd324d2b27c58f5a594f1dc15de | |
| ToppCell | Hippocampus-Neuronal-Inhibitory|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.85e-06 | 182 | 150 | 7 | b54ae650c04dfd0759c5f5e752b9bf684dd36516 | |
| ToppCell | pdx-Tumor_cells-T0|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 3.18e-06 | 185 | 150 | 7 | 1d874608aa2062024323512f68889219471b2f00 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.29e-06 | 186 | 150 | 7 | 8287146f0ba415ea04475588117d4668ae00f75c | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.41e-06 | 187 | 150 | 7 | 71eb26ebf60cb0848e5bf1cd01edccda621aecd8 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.20e-06 | 193 | 150 | 7 | 08696a99309f5b088692ddac8cca35413b5e810d | |
| ToppCell | PCW_07-8.5|World / Celltypes from embryonic and fetal-stage human lung | 4.35e-06 | 194 | 150 | 7 | 5759c83308df017f1faae248e9b85388e25254f0 | |
| ToppCell | COVID-19_Severe-cDC|COVID-19_Severe / Disease condition and Cell class | 4.97e-06 | 198 | 150 | 7 | e0b16627a347e245bedd71b1e0ccdb46c1c1bd6d | |
| ToppCell | COVID-19_Severe-cDC-|COVID-19_Severe / Disease condition and Cell class | 4.97e-06 | 198 | 150 | 7 | 3914140238598914674c08c5ad83354b9485825f | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.14e-06 | 199 | 150 | 7 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M|organoid_Kanton_Nature / Sample Type, Dataset, Time_group, and Cell type. | 5.14e-06 | 199 | 150 | 7 | b2d7dea11207cca63d688f8051143850b29dbdf0 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.31e-06 | 200 | 150 | 7 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | TCGA-Peripheral_Nervous_System-Primary_Tumor-Paraganglioma-Paraganglioma-3|TCGA-Peripheral_Nervous_System / Sample_Type by Project: Shred V9 | 6.55e-06 | 135 | 150 | 6 | ac20133d4a36f48338b45bffb13e842cb66f83ad | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Tac1_Htr1d|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.44e-05 | 155 | 150 | 6 | 79264ff283e36a059040a5aa9fe7337be694cb52 | |
| ToppCell | COVID-19_Moderate-multiplets|World / disease group, cell group and cell class | 1.50e-05 | 156 | 150 | 6 | afdc025fa75e7926b1cc182c4a33654a2186abb1 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Calb2_Pdlim5|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.73e-05 | 160 | 150 | 6 | dd16ca90feb3ae88b6409d6c278b4765da565514 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Lymphocytic-Zbtb32+_B|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.79e-05 | 161 | 150 | 6 | 249c2b97cc25de5053f5048ee354615df49b2081 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.68e-05 | 173 | 150 | 6 | d56e337eae727a29cd53cfd628e1b3c0a98e1f51 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Epithelial-neuro-epithelial-D_cells_(SST+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.05e-05 | 177 | 150 | 6 | 8dbef0005095c01a806d8c7f723dc48a4650efec | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.35e-05 | 180 | 150 | 6 | 1363b3254470f6ff98630d1df83a1bdbacc137e0 | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.45e-05 | 181 | 150 | 6 | 92d44892bb15771f0ab5fe61879b204b0acbd9b3 | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.56e-05 | 182 | 150 | 6 | 81279877b920b5a1bc991a07d3031d6458700fe3 | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.56e-05 | 182 | 150 | 6 | be48ce85991bceeff938ba080e6bf9cc62176b05 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-alveolar_macrophage|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.79e-05 | 184 | 150 | 6 | 8fa30789c9d583188667cf375d2218e392dd40bc | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.90e-05 | 185 | 150 | 6 | 08fad1e3c3cc5f1c3eb6629a49c094b628e75a92 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-alveolar_macrophage-alveolar_macrophage|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.90e-05 | 185 | 150 | 6 | 4bee178ede12f56ba5f5bec44a03dc2a62c50137 | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.02e-05 | 186 | 150 | 6 | f1aa0c58336d23bcbe52a59e7af954d20085bdb6 | |
| ToppCell | IPF-Myeloid-cDC1|World / Disease state, Lineage and Cell class | 4.02e-05 | 186 | 150 | 6 | 962c2dada19185628ead77c32fcb07fa95114247 | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-alveolar_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.02e-05 | 186 | 150 | 6 | 8f77e552e613b6e124443c7f6ef5c1316a5ff8db | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-alveolar_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.14e-05 | 187 | 150 | 6 | f0c6e53035b00772377c4d5f761b4d11026b911a | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.14e-05 | 187 | 150 | 6 | f20e7a1751694390f535ffb27b97e887220f8695 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 4.27e-05 | 188 | 150 | 6 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.27e-05 | 188 | 150 | 6 | 433a25fe52914e07e7ba695881f9bcca2d9467ff | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-alveolar_macrophage-alveolar_macrophage|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.40e-05 | 189 | 150 | 6 | b2542b6fcf7bc10d29158d42b03182a939ff135a | |
| ToppCell | (2)_5-FU-(1)_VE-Cad+_vascular_cells|World / Stress and Cell class | 4.53e-05 | 190 | 150 | 6 | 6b391b8a3ffcbdec3acaf242bc52fc3fc9da77c8 | |
| ToppCell | BAL-Control-Lymphocyte-B-B_cell|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.53e-05 | 190 | 150 | 6 | da7341a8a423e5fe4d8e733d8e50c10a3318ac1c | |
| ToppCell | BAL-Control-Lymphocyte-B-B_cell-B_cell|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.53e-05 | 190 | 150 | 6 | 42312f7d79fe889397d32910b625793e2535cc26 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-alveolar_macrophage|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.53e-05 | 190 | 150 | 6 | da58227565ad6a690828dd8554dd3670222f8582 | |
| ToppCell | BAL-Control-Lymphocyte-B-B_cell-B_cell-B_activate-7|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.53e-05 | 190 | 150 | 6 | 682418a7a2096743112eae3790d40e7e600612c0 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.66e-05 | 191 | 150 | 6 | 5a67ff17fb4b9eff641176dff07830c9cd73754e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.66e-05 | 191 | 150 | 6 | 55ab2854a02cdcfc395e49870ccb7290b5e5471d | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 4.80e-05 | 192 | 150 | 6 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | (1)_Control_(PBS)-(1)_VE-Cad+_vascular_cells|(1)_Control_(PBS) / Stress and Cell class | 4.80e-05 | 192 | 150 | 6 | e16e49b302019474232ef4cc0ff217d33afe34cf | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.80e-05 | 192 | 150 | 6 | bf1943715085c4124b1675888b0615c9500ec888 | |
| ToppCell | Fetal_29-31_weeks-Immune-alveolar_macrophage_(MARCO_positive)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.94e-05 | 193 | 150 | 6 | 2d0dd2671ff27b922eb316f1ed0140353536ef30 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 4.94e-05 | 193 | 150 | 6 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.08e-05 | 194 | 150 | 6 | 4f758718a1233c25c25d99fc1b7b06f906b8b0a2 | |
| ToppCell | Children_(3_yrs)-Immune-monocyte-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.23e-05 | 195 | 150 | 6 | 81a28289eda1a8a1a31b7357106f64ac5000e172 | |
| ToppCell | (1)_Control_(PBS)-(1)_VE-Cad+_vascular_cells|World / Stress and Cell class | 5.23e-05 | 195 | 150 | 6 | 6b5d3ecec0c00ebfc889dc6235390ff53b5c0b6a | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.38e-05 | 196 | 150 | 6 | 7e5addaa844e66f8160e05858c341866a80aed23 | |
| ToppCell | COVID-19-kidney-TAL|kidney / Disease (COVID-19 only), tissue and cell type | 5.38e-05 | 196 | 150 | 6 | 04f5eb206ed3016a737609a3ebac0c1fcabb94ef | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.53e-05 | 197 | 150 | 6 | b597c292fc1cb381a4325fed15a32966c38def28 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.53e-05 | 197 | 150 | 6 | bf10727fbe90b71d2ac60a11711e5f0701b3799d | |
| ToppCell | tumor_Lung-Epithelial_cells-tS1|Epithelial_cells / Location, Cell class and cell subclass | 5.53e-05 | 197 | 150 | 6 | 7190143468939cf26c069d125a5e88e4bf026299 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-2_Progenitor-AT1_Progenitor|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.69e-05 | 198 | 150 | 6 | c30a517ca5f803273f1517e27995082ec4e07c76 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_aging_sig-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.85e-05 | 199 | 150 | 6 | b0a906586e58009f5ed9272fc29ba28e49c85ee6 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-ADGRG6-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 6.02e-05 | 200 | 150 | 6 | a9cdddc4e985dae59521e557479c24fcc2ac727d | |
| ToppCell | Neuronal-Inhibitory|Neuronal / cells hierarchy compared to all cells using T-Statistic | 6.02e-05 | 200 | 150 | 6 | 9ff8647e2de0b538e15929dca88ebb20ff7ab043 | |
| ToppCell | TCGA-Bile_Duct-Primary_Tumor-Cholangiocarcinoma-Intrahepatic|TCGA-Bile_Duct / Sample_Type by Project: Shred V9 | 6.02e-05 | 200 | 150 | 6 | 1fa8422fd820d21e285a7e7c4c6fbd8b7277d2af | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-ADGRG6--L3-5|Neuronal / cells hierarchy compared to all cells using T-Statistic | 6.02e-05 | 200 | 150 | 6 | 33b9199e0dfc267e2cea20b82d1c167f8adcc635 | |
| ToppCell | COVID-19-COVID-19_Severe-Myeloid-cDC|COVID-19_Severe / Disease, condition lineage and cell class | 6.02e-05 | 200 | 150 | 6 | e7b808d8ed65343a4345fafb03015fe4f7ce302f | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type. | 6.02e-05 | 200 | 150 | 6 | ac0e023dbb383bbc46c5cc525431778be8f7ef46 | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 6.02e-05 | 200 | 150 | 6 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-NMBR|Neuronal / cells hierarchy compared to all cells using T-Statistic | 6.02e-05 | 200 | 150 | 6 | 862db57d043bdf3cb059fbfc8b29bc1eafdf64ec | |
| ToppCell | Neuronal-Inhibitory-iA|Neuronal / cells hierarchy compared to all cells using T-Statistic | 6.02e-05 | 200 | 150 | 6 | 5ef4a3dc18a44292184a59ced916183c0699b01e | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-NMBR--L1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 6.02e-05 | 200 | 150 | 6 | a91345f268f13170c27309333603eb82400c9947 | |
| ToppCell | COVID-19-COVID-19_Mild-Myeloid-cDC|COVID-19_Mild / Disease, condition lineage and cell class | 6.02e-05 | 200 | 150 | 6 | b8f52e65813d331c49cdd5f354fdfec6fc8c339e | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Neuronal-Intermediate|6m / Sample Type, Dataset, Time_group, and Cell type. | 6.02e-05 | 200 | 150 | 6 | 7c261e39ac30b318511373ab7302aa53b8b81b9c | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-ADGRG6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 6.02e-05 | 200 | 150 | 6 | 9719fabddc34051949468a7520289e3c750de4f8 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-NMBR-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 6.02e-05 | 200 | 150 | 6 | d416a7be1a4e6232fb58a9687774da24821f1fdd | |
| ToppCell | mild-T/NK_proliferative|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.02e-05 | 200 | 150 | 6 | 63cc57b9331459efbb73051d174d198a3568b938 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Calb2_Necab1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.80e-05 | 126 | 150 | 5 | 28fbe63f7bc628b32d8e86bf9e80657e776dd1cc | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Tac1_Htr1d|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.08e-04 | 139 | 150 | 5 | fe1657ef9aeda7c530dc7febcd3dcd0e1d5f8a48 | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Synpr|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.28e-04 | 144 | 150 | 5 | 04f9054895be2275eecda687a6eeb02fa5ec69b9 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Granulocytic-Neutrophil-Neu_c6-FGF23|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.70e-04 | 153 | 150 | 5 | 8bc09b8b1a32a8d7ac8201c626d2b306e7cc2972 | |
| ToppCell | TCGA-Thryoid-Solid_Tissue_Normal-Thryoid_normal_tissue-Thryoid_normal_tissue-3|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 1.75e-04 | 154 | 150 | 5 | 4e9203c220a44c70cd7979796a0b461991422257 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.80e-04 | 155 | 150 | 5 | 441fcb6d05364fc6f4973f0b973f1a80b573ce1f | |
| ToppCell | 10x5'-Lung-Lymphocytic_T_CD4-T_CD4/CD8|Lung / Manually curated celltypes from each tissue | 1.86e-04 | 156 | 150 | 5 | 10d191e29b16cae8238e8df6c0ff38882253f34e | |
| ToppCell | 343B-Myeloid-Macrophage-SPP1+_Macrophage|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.91e-04 | 157 | 150 | 5 | 4183dbed6b31ebe13ef33eb19ba6d0fb4f625953 | |
| ToppCell | TCGA-Bladder-Solid_Tissue_Normal-Urothelial_normal_tissue-Urothelial_normal_tissue|TCGA-Bladder / Sample_Type by Project: Shred V9 | 2.09e-04 | 160 | 150 | 5 | 8a41e2c96e0e170ac35daf6c403bf961b8d7c30b | |
| ToppCell | TCGA-Bladder-Solid_Tissue_Normal|TCGA-Bladder / Sample_Type by Project: Shred V9 | 2.09e-04 | 160 | 150 | 5 | d6678996e12eaf2b735f1dfae32418cb2fabf268 | |
| ToppCell | TCGA-Bladder-Solid_Tissue_Normal-Urothelial_normal_tissue|TCGA-Bladder / Sample_Type by Project: Shred V9 | 2.09e-04 | 160 | 150 | 5 | c8dc575562b463fd30832d322c28006f18f7ab9c | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Calb2_Pdlim5|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.15e-04 | 161 | 150 | 5 | bf70be1de418615b5442ec684552551edaf1f072 | |
| ToppCell | wk_08-11-Mesenchymal-Myofibro_&_SMC-Late_airway_SMC|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.27e-04 | 163 | 150 | 5 | 1e8730d75cccf7292010683ab4e81a69d8e3bfa9 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.27e-04 | 163 | 150 | 5 | 6bed27d2f67a430a847da5eb47878d14b4949c45 | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.47e-04 | 166 | 150 | 5 | 575c325db88d6909cdf0d5e664bd9098b89d4401 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.54e-04 | 167 | 150 | 5 | b94e8ee8c3fcebedd8fcd719eadddc04c7513c50 | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.54e-04 | 167 | 150 | 5 | 9a84f45345c75f2c8ff38a04245aadee2a26a240 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)-Club_(non-nasal)_L.0.4.1.3|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.54e-04 | 167 | 150 | 5 | 8fede587572d465cb63f7828141a574185bbb819 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.62e-04 | 168 | 150 | 5 | fa0d251693935116adf633d02b7ec4a295100865 | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Lrg1_(Lrg1)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.64e-04 | 92 | 150 | 4 | ed282f0f3da1593bdec5a2b20af5b8f058574167 | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Lrg1_(Lrg1)--|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.64e-04 | 92 | 150 | 4 | c5f30d58f235f7a72dfe63f58999c4680502576f | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Lrg1_(Lrg1)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.64e-04 | 92 | 150 | 4 | 27072dbf6819dca41e41267dc250abfaaf175b2f | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.69e-04 | 169 | 150 | 5 | 16c52a0f6d96ecc1832922fce9b39691849f0d73 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Hematologic-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.69e-04 | 169 | 150 | 5 | 4e1322cc5e1733e9fb19e08f739a30206f43cea8 | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.69e-04 | 169 | 150 | 5 | a1efc20e34a81ae32f8d278a5486811ade03ef24 | |
| Drug | thymine | ERCC4 CLTCL1 TENT4A PDHA2 PDHB POLA1 MTSS1 APC PGPEP1 BRCC3 BCKDHB GRIN2D PGK1 QKI | 1.51e-08 | 315 | 145 | 14 | CID000001135 |
| Drug | guanine | AMPD2 TRIO TENT4A NSF POLA1 APC BCKDHB GRIN2D CXXC1 PGK1 PREX2 KLHL20 ARCN1 BST1 NGEF PLCB2 GNAI1 GNAI3 RAB3B RASGRP2 | 1.20e-06 | 902 | 145 | 20 | CID000000764 |
| Drug | BIPM | 4.51e-06 | 18 | 145 | 4 | CID000117909 | |
| Drug | Dynasore hydrate | 8.69e-06 | 7 | 145 | 3 | CID005396227 | |
| Drug | Na 7 | 1.38e-05 | 8 | 145 | 3 | CID000446006 | |
| Drug | 1,4-bis-(phenoxyacetyl)piperazine | 1.45e-05 | 225 | 145 | 9 | CID001008511 | |
| Disease | epilepsy (implicated_via_orthology) | 1.84e-05 | 163 | 147 | 7 | DOID:1826 (implicated_via_orthology) | |
| Disease | cholangiocarcinoma (is_implicated_in) | 1.74e-04 | 22 | 147 | 3 | DOID:4947 (is_implicated_in) | |
| Disease | primary biliary cholangitis (biomarker_via_orthology) | 3.62e-04 | 28 | 147 | 3 | DOID:12236 (biomarker_via_orthology) | |
| Disease | Intellectual Disability | 4.23e-04 | 447 | 147 | 9 | C3714756 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 4.51e-04 | 195 | 147 | 6 | DOID:1574 (implicated_via_orthology) | |
| Disease | bitter alcoholic beverage consumption measurement | 5.52e-04 | 133 | 147 | 5 | EFO_0010092 | |
| Disease | prostate cancer (implicated_via_orthology) | 5.92e-04 | 33 | 147 | 3 | DOID:10283 (implicated_via_orthology) | |
| Disease | McCune Albright syndrome (implicated_via_orthology) | 6.77e-04 | 8 | 147 | 2 | DOID:1858 (implicated_via_orthology) | |
| Disease | ovarian cancer (implicated_via_orthology) | 6.77e-04 | 8 | 147 | 2 | DOID:2394 (implicated_via_orthology) | |
| Disease | glioblastoma (implicated_via_orthology) | 8.67e-04 | 9 | 147 | 2 | DOID:3068 (implicated_via_orthology) | |
| Disease | pregnenediol disulfate (C21H34O8S2) measurement | 1.32e-03 | 11 | 147 | 2 | EFO_0800279 | |
| Disease | endometrial carcinoma (is_implicated_in) | 1.57e-03 | 12 | 147 | 2 | DOID:2871 (is_implicated_in) | |
| Disease | Diverticular Bleeding | 1.85e-03 | 13 | 147 | 2 | C4505353 | |
| Disease | Diverticular Diseases | 1.85e-03 | 13 | 147 | 2 | C4317009 | |
| Disease | glycochenodeoxycholate glucuronide (1) measurement | 1.85e-03 | 13 | 147 | 2 | EFO_0800474 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 1.86e-03 | 447 | 147 | 8 | EFO_0000694, MONDO_0100096 | |
| Disease | pathological myopia | 2.34e-03 | 111 | 147 | 4 | EFO_0004207 | |
| Disease | hepcidin:transferrin saturation ratio | 2.48e-03 | 15 | 147 | 2 | EFO_0007902 | |
| Disease | ecosanoids measurement | 2.63e-03 | 55 | 147 | 3 | EFO_0020044 | |
| Disease | Benign neoplasm of stomach | 3.19e-03 | 17 | 147 | 2 | C0153943 | |
| Disease | Tactile Amnesia | 3.19e-03 | 17 | 147 | 2 | C0750906 | |
| Disease | Amnestic State | 3.19e-03 | 17 | 147 | 2 | C0750907 | |
| Disease | Dissociative Amnesia | 3.19e-03 | 17 | 147 | 2 | C0236795 | |
| Disease | Neoplasm of uncertain or unknown behavior of stomach | 3.19e-03 | 17 | 147 | 2 | C0496905 | |
| Disease | Hysterical amnesia | 3.19e-03 | 17 | 147 | 2 | C0233750 | |
| Disease | Temporary Amnesia | 3.19e-03 | 17 | 147 | 2 | C0233796 | |
| Disease | Carcinoma in situ of stomach | 3.19e-03 | 17 | 147 | 2 | C0154060 | |
| Disease | Amnesia | 3.19e-03 | 17 | 147 | 2 | C0002622 | |
| Disease | Global Amnesia | 3.19e-03 | 17 | 147 | 2 | C0262497 | |
| Disease | banks of the superior temporal sulcus volume measurement | 3.19e-03 | 17 | 147 | 2 | EFO_0010286 | |
| Disease | Stomach Carcinoma | 4.86e-03 | 21 | 147 | 2 | C0699791 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ESCGEGSMKVLEKRL | 236 | Q10588 | |
| GLKAMGREICLREKT | 901 | A6H8Y1 | |
| GIGIVKEDDMTDCLS | 2401 | Q96N23 | |
| AVRTMGCIRVDKITE | 106 | P63010 | |
| CDEERLDIMKVLITG | 4601 | Q9NR09 | |
| EVRIKMVAVGICGTD | 36 | P07327 | |
| EGDVVQCIRDTSKVM | 271 | P43652 | |
| EVRIKMVAAGICRSD | 36 | P00326 | |
| SMDKDCLRTGDKATV | 526 | O00178 | |
| DMVAKLESECLKRQG | 281 | Q9NWN3 | |
| TEMGDVACTKIAKVE | 426 | Q68CP9 | |
| KLECELEALVGRMEA | 396 | Q86XR8 | |
| TLEECRVTLEGLKME | 536 | Q5M775 | |
| MEQLSRALKETEGGC | 626 | Q9P2G1 | |
| VGVKDDRMGEEICAC | 541 | Q96CM8 | |
| VSKIIERCSAEVGRM | 591 | O94989 | |
| AVRTMGCIRVDKITE | 106 | Q10567 | |
| RCTKEMEGDTQKLEV | 1866 | A6QL64 | |
| ATIRCTKEMEGDTQK | 1301 | Q8N2N9 | |
| RTSMDGKCKEIAEEL | 116 | Q01433 | |
| VCKREITIMKELSGH | 91 | Q9NSY1 | |
| LEEKVKAVEGMCSVR | 361 | Q9BXF3 | |
| MIAGEERALCLVDVK | 1646 | O14578 | |
| GREDVKMVGEKCDVL | 91 | P49418 | |
| MRIGLTEEFCVGKSE | 226 | O00189 | |
| KNIRTDIVMDVGCSI | 1181 | Q06278 | |
| TSGEKGVRIKECRVM | 511 | Q9NW13 | |
| KQLEAETGCKIMVRG | 111 | Q96PU8 | |
| ILVGNKCDMEEERVV | 131 | P20337 | |
| KCDMEEERVVPTEKG | 136 | P20337 | |
| SKCAEIDREMISSLG | 131 | Q92878 | |
| DRGLCQMVRVGSKTE | 941 | A6NNM3 | |
| DRGLCQMVRVGSKTE | 941 | A6NJZ7 | |
| MGCTLSAEDKAAVER | 1 | P63096 | |
| SVEACIRTLAMVAKG | 1521 | Q14573 | |
| MEKRGESLDLGVRCK | 1 | Q8N7Y1 | |
| KCLAVGMVKEVVRTD | 326 | P22736 | |
| SSEMCRDLAGEVEKL | 131 | O43747 | |
| ATIRCTKEMEGDAQK | 1726 | Q5JPF3 | |
| EVASMAKEKLGVSCE | 286 | P21953 | |
| LSKEGVECEVINMRT | 256 | P11177 | |
| TDSVILIKCDERGKM | 296 | Q05329 | |
| ICKVLRDGIMRVGKT | 1456 | Q71F56 | |
| LCEAATSDMDIGKRK | 286 | Q9H0U3 | |
| MGCTLSAEDKAAVER | 1 | P08754 | |
| MAGTLDLDKGCTVEE | 1 | Q7LDG7 | |
| SRKTGVENVMAKEIC | 441 | O43187 | |
| SKCEEMKATVIRHGE | 316 | P78386 | |
| VLGMKVESCSVARLE | 26 | Q9HC38 | |
| SRATGRCLEVEMSKD | 561 | Q9HCQ5 | |
| TADEMCKALLEVLGR | 196 | Q16775 | |
| DAKVACETVAKTGMI | 51 | P31153 | |
| VELLMDAEGKSRGCA | 101 | P52272 | |
| MCKKVLTGVAGEDAE | 721 | O95373 | |
| RHICGGKTEMEIAKL | 426 | P29536 | |
| MEAVIEKECSALGGL | 1 | O43312 | |
| CMKAVCKRVAVEGVD | 101 | A6NFU8 | |
| DMDAVCKRVTTLGLD | 121 | Q9NXJ5 | |
| TRGKILLCTGAIMEE | 161 | Q8WVE0 | |
| SKCEEMKATVIRHGE | 131 | A6NCN2 | |
| DKAKQCIGTMTIEID | 86 | P46459 | |
| GQRVCVIDEIGKMEL | 106 | Q9BSD7 | |
| ELELGVVMGKRCRAV | 71 | Q6P587 | |
| VLRGITCDIGSMEKI | 1316 | Q92887 | |
| TCDIGSMEKIGVVGR | 1321 | Q92887 | |
| GDAAEVKRCKNMEVL | 786 | Q07864 | |
| VLDATKRLGCEEMEG | 291 | Q6A1A2 | |
| MDEVVKATSRGCITI | 356 | P00558 | |
| DCRTGMLTVVKKLDR | 516 | Q9BZA7 | |
| CGRMICDVEISAKEL | 686 | P09884 | |
| CIGSRIHIVMKSDKE | 21 | Q9Y4Y9 | |
| GMDSRIKIKERIATC | 541 | Q5XG87 | |
| ETEKLSIMIEECGGL | 456 | P52292 | |
| SIMIEECGGLDKIEA | 461 | P52292 | |
| VKTQMSLGKLCVEER | 916 | O43283 | |
| DEVIFMKEGCITERG | 751 | O15440 | |
| MKEGCITERGTHEEL | 756 | O15440 | |
| TAGEEEMIKIRSCAE | 171 | Q14331 | |
| DQKSGGKCETDRRMV | 2091 | Q3L8U1 | |
| HGDCIRITEKMAKAI | 51 | Q9P0U4 | |
| MSKRRCGVGVSVLDD | 351 | Q9Y2M5 | |
| SIRKMEGHDGIEKVC | 161 | Q8TDB6 | |
| GRKMGLECVDILSEL | 236 | Q9UKT4 | |
| KERDAICMSLDGLRK | 906 | Q5TH69 | |
| DLLKGVADMLERECT | 451 | Q96SY0 | |
| VVKECRAVVIAGGTM | 611 | A8MPP1 | |
| KVILRKCAEGEMQGV | 2381 | Q8WXX0 | |
| AGCMVNKRELTEDGL | 126 | A0PJE2 | |
| AVVKELCTTRVLGME | 311 | Q96D53 | |
| AAEVCREGLKGLEML | 786 | Q8TF61 | |
| RCLVVDEADRMVEKG | 466 | Q9GZR7 | |
| KTGRKERMECETDEQ | 196 | Q9NWQ4 | |
| MVKKISITERSCDGA | 401 | Q63ZY3 | |
| KKSEGLTQSMVDRCI | 446 | Q9P2N6 | |
| MALSLEEEAGRIKDC | 1 | Q9BZB8 | |
| MRKIDLCLSSEGSEV | 1 | Q9Y547 | |
| DDKLVVECVMKGVTS | 111 | P15090 | |
| ARMAVGCVIELASKV | 751 | Q9UKV0 | |
| EIECRLVEAVDGKAM | 366 | Q8NBJ5 | |
| QRVAEEMKCTLGSKV | 116 | Q8IX18 | |
| LKCIRIGSMEDSAKA | 101 | P56856 | |
| KCRTAGIRVIMVTGD | 616 | P20648 | |
| MKIEEKITLTCGRDG | 276 | P48444 | |
| LKETTEEIRQMGTEC | 76 | O75911 | |
| MIECSARDILVKGVD | 391 | Q0VDF9 | |
| KVDGMDVLCVREATK | 251 | P29803 | |
| KCLSVGMVKEVVRTD | 351 | Q92570 | |
| RDVSGVVMECGLDVK | 121 | Q8WWV3 | |
| STTVKVMGEELCLVR | 236 | Q9NSD7 | |
| GDNGKEIRKMCEVVL | 226 | Q08AM6 | |
| GEDEVSCETVKMGRK | 196 | Q96TC7 | |
| SCETVKMGRKDSLDL | 201 | Q96TC7 | |
| INCEAKGIKMVSEIS | 46 | Q9H5Y7 | |
| TRMLDCVRSDGKSVD | 1246 | Q9UPZ6 | |
| DRGLCQMVRVGSKTE | 941 | Q9UFD9 | |
| ELEMVVKACNEGVRK | 446 | Q8N5V2 | |
| VKACNEGVRKMSRTE | 451 | Q8N5V2 | |
| KDALSKDVMVVGCVA | 626 | Q7Z3Z4 | |
| ETICRVTGGMKVKAD | 51 | P62263 | |
| GSVVKARVLTCVEGM | 86 | Q86WV5 | |
| LRCMKSEEKSLGVGL | 536 | P46721 | |
| TVDKLCRVEQDLAMG | 361 | P61764 | |
| GEECELETMTGEKVK | 66 | P07148 | |
| ALSTEKEEVMGLCIG | 26 | P46736 | |
| KTLREVGSVKALMEC | 561 | P25054 | |
| VGSVKALMECALEVK | 566 | P25054 | |
| TMESDKFICIREKVG | 31 | Q00610 | |
| TMESDKFICIREKVG | 31 | P53675 | |
| IRGICEMELLDGKQT | 996 | Q15021 | |
| MDRAVAEGKRVCVID | 456 | Q13057 | |
| GKVLMAKQEIVECVA | 191 | Q86W11 | |
| SSDVIEMKGRVACEI | 866 | P42285 | |
| KICGVEDAVSEMTRR | 36 | P78330 | |
| RLGSEVLMSDLKCET | 546 | Q96PX8 | |
| KESGERLSKMVEDAC | 206 | Q96P16 | |
| REIADGLCLEVEGKM | 21 | P13693 | |
| GLCLEVEGKMVSRTE | 26 | P13693 | |
| DLMCTGDKDVVNEGR | 131 | Q8NEB5 | |
| GIDIICNAEKEGKTM | 261 | Q8IZM8 | |
| TCVTIGEKKNEALME | 261 | Q92576 | |
| DSTAGIKCNVVEKMI | 826 | Q70Z35 | |
| QEGESTLEIRKMGSC | 736 | O95359 | |
| MKGLEAEVKESVRAC | 1131 | Q00722 | |
| EGAKTLECTMRGVLR | 731 | Q9P2E3 | |
| TGKTARAIRDMCLEK | 731 | O75643 | |
| IDVTRQADCKMKLGD | 196 | Q9UPP1 | |
| VCLEMLGESAAKKVA | 851 | Q6R2W3 | |
| EMCVERKSISDLIGS | 721 | Q92889 | |
| EGRTGMAEKKLADCE | 36 | Q6NUN9 | |
| RVMSRGEGDCDVVKS | 206 | Q9NV66 | |
| AEDGCISTKELGKVM | 31 | P63316 | |
| CSASEKVQEKEEGRM | 211 | Q8N228 | |
| VMSRGEGDCDVVKSK | 161 | Q6NUM6 | |
| SEEVCKRGFTVIVDM | 116 | O75962 | |
| RDKIAQIDKVMCEGS | 256 | Q9P1Q0 | |
| KGGLLSTDDKEEMCR | 361 | Q5THJ4 | |
| CSLDVVLKEGGEMTT | 246 | B1AL88 | |
| IHRIKCDKATGIIEM | 1061 | P54296 | |
| IGSMDVVKCKRAAEI | 3156 | P20929 | |
| MARKDEGCKLVTIGS | 766 | O15399 |